Cargando…
Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most eff...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779898/ https://www.ncbi.nlm.nih.gov/pubmed/33394351 http://dx.doi.org/10.1007/s12250-020-00327-x |